久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China approves first domestically produced nine-valent HPV vaccine

Xinhua | Updated: 2025-05-30 16:14
Share
Share - WeChat

XIAMEN -- China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the National Medical Products Administration.

The vaccine, Cecolin 9, was jointly developed by the Xiang An Biomedicine Laboratory, Xiamen University and Wantai BioPharm. Its approval makes China the second country in the world — after the United States — with the capability to independently supply high-valency HPV vaccines.

Since 2019, the vaccine has been through five clinical trials conducted across China, involving more than 11,000 healthy volunteers aged nine to 45.

Results from these trials showed that the vaccine provides strong protection against HPV types 16 and 18 — the same strains covered by the two-valent vaccine — as well as five other HPV types 31, 33, 45, 52 and 58, with a protection rate of over 98 percent against persistent infections lasting more than 12 months and a 100 percent protection rate against cervical infections.

For girls aged nine to 17, just two doses are sufficient to produce an immune response comparable to that seen in women aged 18 to 26 who receive three doses. For girls aged 15 to 17, it is currently the only two-dose HPV vaccine available in China.

A comparative study showed that the new vaccine offers immune responses comparable with similar international products for at least 30 months after full immunization. These findings have been published in The Lancet Infectious Diseases.

The new vaccine is the latest achievement from the research team that also developed China's first domestically made two-valent HPV vaccine in 2019. In 2021, the two-valent HPV vaccine received prequalification from the World Health Organization (WHO) and has since entered the markets of 21 countries.

Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. China made free HPV vaccination accessible to approximately 40 percent of girls aged 13 to 14 in 2024, as part of its ongoing work to tackle cervical cancer, according to the National Health Commission.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美一区二区三区不卡片 | 精品国产自在现线看久久 | 亚洲国产天堂久久综合网站 | 久久久全国免费视频 | 精品在线一区 | 亚洲欧美成人综合久久久 | 午夜性爽爽爽 | 国产成人精品999在线观看 | 日本三级成人午夜视频网 | 91久久香蕉青青草原娱乐 | 欧美三级一区二区三区 | 免费看美女无遮掩的软件 | 亚洲国产日韩女人aaaaaa毛片在线 | 在线观看一区二区三区视频 | 国产欧美日韩在线观看一区二区三区 | 免费国产成人高清无线看软件 | 国产真实生活伦对白 | 在线一区二区三区 | 国产精品国产高清国产专区 | 一区二区三区 日韩 | 国产成人亚洲毛片 | 国产不卡在线播放 | 韩国一级片视频 | 久久久久亚洲香蕉网 | 欧美高清在线视频一区二区 | 东莞a级毛片 | 欧美xxxxx色视频在线观看 | 亚洲欧美成人影院 | 欧美一区二区在线免费观看 | 国产黄色三级 | 久久精品夜色国产 | 91亚洲国产成人久久精品网站 | 成人午夜免费视频毛片 | 欧美日本韩国一区 | 成年人免费在线视频观看 | 亚洲免费不卡 | 午夜刺激爽爽视频免费观看 | 131美女爱做免费毛片 | 久久国产三级 | 精品国产1区 | 国产美女在线精品观看 |